|
British Columbia has Cause to Celebrate
May 4, 2006 BC Biotech is proud to be hosting our 8th Annual BC Biotechnology Awards Ceremony May 4th to honour outstanding contributions made by members of British Columbia's biotechnology community. This event has evolved to become the premier evening of the year for biotech in BC, and we hope to have you all join us in this year's celebration. We are extremely pleased to announce that this year, in order to expand the breadth of our awards, and be increasingly inclusive of the greater life sciences community, BC Biotech has partnered with Genome British Columbia to create the Genome BC Award for Scientific Excellence. This award will be presented to an individual who has received significant international recognition in the fields of genomics, proteomics, bioinfomatics or systems biology. We thank Genome British Columbia for being an important new partner for us.
Tickets are Now Available Tickets are on sale, and tables are assigned on a first come, first serve basis, so register early. Ticket prices are as follows: Member Table (10 seats) - $1100.00 + GST Individual Member Ticket - $125.00 + GST For more information about the BC Biotechnology Awards contact Barry Gee, Director, Operations and Communications at (604) 602-5226 or bgee@bcbiotech.ca The 8th Annual BC Biotechnology Awards are presented by:
The New International Financial Centre Legislation re: Life Sciences Patents….What it Really Means for all BC Biotech Companies
To view Deborah Brown's presentation, please click here Brief presentations highlighting exciting early-stage companies were also made. Andrew Rae, CEO of iCo Therapeutics gave a synopsis of his company and the market potential for their lead product iCo-007 for treating age-related macular degeneration and diabetic retinopathy . Bill Garner, CEO of Urigen talked about Urigen's recent move to BC from California, and provided an overview of their product U101, used in the treatment of interstitial cystis. Thank you to our sponsors, KPMG and McCarthy Tetrault LLP for their ongoing support.
It's that time of the year again to renew your BC Biotech membership for 2006-2007. Membership renewal forms will be sent shortly to the primary contacts of each organization, and renewals can be made online. Please note that in order for your membership to remain active, we would appreciate that you renew your BC Biotech membership by March 31st. If you have any questions about membership renewals, please contact Raman Bhullar at rbhullar@bcbiotech.ca or at 604-602-5228.
BC Biotech was very successful in introducing a new organizational sponsorship program last year, and would like to take this opportunity to invite you to be a part of it. We are pleased to announce that in the first six months of this new program, we had 21 sponsors confirmed. Without the support of our sponsors, we could not have undertaken all our new programs and initiatives in this past year, including the development of the BC Biotech position paper, facilitating linkages between pharma and our industry and developing a video promoting the benefits of investing in British Columbia. Please view our 2006-2007 Sponsorship Program If you have any further questions about the program or would like more information, please contact Raman Bhullar at rbhullar@bcbiotech.ca or 604-602-5228.
March 30-31, 2006 The next offering of Biotech 101 will be March 30-31, 2006 at Townsquare C at the BCIT Burnaby Campus from 9:00 am - 4:30 pm.Offered in partnership by BC Biotech and BCIT, and taught by Dr. Paul Barran, Biotech 101 is a popular two-day course that provides a comprehensive overview of the basic principles, technologies, and applications of biotechnology. The cost of Biotech 101 is $695 + GST for BC Biotech Members and $925 + GST for Non-members (the fee includes the cost of all course materials as well as lunch and snacks).
CEO AND INVESTOR FORUM Invest Northwest is the leading investment conference for Pacific Northwest life science community. Invest Northwest is in its fourth year of facilitating relationships between bioscience investment professionals and medical device, biotechnology and related companies. This conference provides bioscience companies an ideal venue to network, identify opportunities and expose the investment community to the width and breadth of this regions’ life science sector. Companies present business plans to an international audience of investors ranging from certified angels, venture capitalists, mezzanine level funds, pension fund managers, analysts and institutional investors. This is your opportunity to hear from this region’s emerging and established companies, as well as the most active investors in the bioscience industry. In addition to the presentations, Invest Northwest features intriguing panel topics focused on the dynamics of the pharmaceutical industry and its impact on biotech, biotech market cycles, what’s hot in biotech, what’s hot in medical devices, what investors look for in a bioscience company and how to create a culture of innovation and commercialization. An evening reception will close the forum’s opening day, affording an opportunity for attendees to network in a casual setting. Invest Northwest is hosted by the Washington Biotechnology and Biomedical Association, in collaboration with BC Biotech, BC MedTech, BioAlberta, Idaho Bioscience Association, Montana Bioscience Alliance and the Oregon Bioscience Association. For more information about the conference, please contact : Washington Biotechnology & Biomedical Association Sponsorship:
April 28, 2006
BC Biotech is proud to be the lead organizer for the sanofi-aventis biotech challenge (SABC) in BC. The sanofi-aventis biotech challenge is a high-school competition held nationwide that brings together creative and curious young people interested in solving a problem using biotechnology. The final competition for British Columbia students will be held on April 28, 2006 in Townsquare A,B,C,D at BCIT's Burnaby Campus. The SABC Awards will be presented to the winners at the 8th Annual BC Biotechnology Awards For more information on the sanofi-aventis biotech challenge visit the program website at www.biotechchallenge.ca |
||||||||
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |